
1 

(1) These Regulations may be cited as the National Health Service (General Medical and Pharmaceutical Services) (Scotland) Amendment (No.3) Regulations 1987 and shall come into force on 1st September 1987.
(2) In these Regulations “the principal Regulations” means the National Health Service (General Medical and Pharmaceutical Services) (Scotland) Regulations 1974().
2 
In Schedule 1 to the principal Regulations (terms of service for doctors) in paragraph 16A(2)(b)() for the words “treatment of the condition” there shall be substituted the word “purpose”.
3 
In Schedule 2A to the principal Regulations (drugs and other substances not to be supplied by general medical practitioners or prescribed for supply under pharmaceutical services)() the following entries shall be deleted:–
 Dynese Plus Aqueous Suspension
 Haymine Tablets
 Kolanticon Gel
 Polycrol Forte Tablets
 Polycrol Gel
 Polycrol Tablets
 Pregnavite Forte F Tablets.
4 
In Schedule 2A to the principal Regulations each of the following entries shall be inserted at the appropriate point in the alphabetical order:–
 Fiberform
 Octovit Tablets.
5 
For Schedule 2B to the principal Regulations (drugs to be supplied by general medical practitioners or prescribed for supply under pharmaceutical services only in certain circumstances)() there shall be substituted the Schedule 2B set out in the Schedule to these Regulations.
6 
Regulation 3 of the National Health Service (General Medical and Pharmaceutical Services) (Scotland) Amendment (No. 5) Regulations 1985() is hereby revoked.
Michael B. Forsyth
Parliamentary Under Secretary of State, Scottish Office
New St. Andrew’s House,
Edinburgh
3rd August 1987
SCHEDULE
Regulation 5

“
SCHEDULE 2B
Regulation 2(1)


1 2 3
Drug Patient Purpose
Acetylcysteine Granules Any patient Treatment of abdominal complications associated with cystic fibrosis
Carbocisteine A patient under the age of 18 who has undergone a tracheostomy Treatment of any condition which, through damage or disease, affects the airways and has required a tracheostomy
Clobazam Any patient Treatment of epilepsy
Pregnavite Forte F Tablets A woman who has previously given birth to a child (whether or not born alive) with a defect of the neural tube or aborted a foetus with such a defect Reduction of the risk of spina bifida or anencephaly in a child which may be born to the patient”.
